6 August 2020

Oxford PharmaGenesis colleagues volunteer their time to collate COVID-19 research for Evidence Aid

Throughout the COVID-19 pandemic, our colleagues have volunteered their time in many different and inspiring ways. Read more about the experiences of two of our colleagues.

Continue reading

3 July 2020

Oxford PharmaGenesis at the first virtual Communiqué Awards

This year saw the first virtual edition of the Communiqué Awards, with Oxford PharmaGenesis strongly represented among a multitude of faces online, celebrating excellence in international healthcare communications. While the COVID-19 pandemic precluded the razzmatazz of the usual black-tie dinner and awards ceremony in London, the virtual event nevertheless continued the Communiqué mission to recognize work that has delivered real improvements in healthcare and patient experience, built trust among wider stakeholders and augmented the reputation of our industry over the past year.

Continue reading

5 June 2020

A message from Oxford PharmaGenesis

We are watching, with you, the events that are unfolding in the USA. At Oxford PharmaGenesis, we value diversity of culture and of opinion in our aspiration to uphold an environment in which employees can be themselves and express their views. This ideal is woven into our company’s philosophy, which speaks to maintaining a workplace that is both supportive and diverse.

Continue reading

5 June 2020

How was Virtual ASCO 2020?

We were excited to participate in the first ever ASCO virtual annual meeting last week. Although we missed the in-person interactions, we did not miss the travelling, and it was great to hear about all the exciting developments in cancer research from the comfort of our own homes!

Continue reading

28 May 2020

HEOR and RWE in the COVID-19 pandemic: highlights from the first virtual ISPOR meeting

HEOR and RWE in the COVID-19 pandemic: highlights from the first virtual ISPOR meeting

In May 2020, members of the Oxford PharmaGenesis Value Demonstration Practice joined more than 1300 health economic and outcomes research (HEOR) and market access professionals from 54 countries for the first ever fully virtual ISPOR meeting, participating in a broad range of presentations, workshops and symposia across the three-day conference. Although real-world evidence (RWE) and HEOR methods were naturally the focus, the COVID-19 global pandemic took centre stage in many presentations and discussions. Nevertheless, there was broad agreement that the role of RWE and HEOR in healthcare decision-making will continue to grow in the coming years.

Continue reading
1 2 3 28